Adequacy of access to investigative drugs for seriously ill patients: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997, Volume 4
U.S. Government Printing Office, 1997 - Medical - 78 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
agency allow Ampligen answer antiferritin Antineoplastons Barton believe bone marrow bone marrow transplant Burr Burzynski clinic cancer Cancer Center CFIDS Chairman chemotherapy chronic fatigue immune chronic fatigue syndrome clinical hold clinical trial committee compassionate Congress David Smith decision doctor efficacy Evans executive session experimental drugs fatigue immune dysfunction FDA officials FDA's Frances Langham Friedman gentleman Gochenour going Greenwood hearing Hodgkin's disease hope Houston husband illness IND holders issue Jaffe Jim Greenwood JOE BARTON John Millener Judy Kay Smith Klink legislative letter lives Maplethorpe MD Anderson ment Myotrophin option pain panel patients physicians Prepared Statement problem protocol questions response risk Ron Klink safe safety Senator side effects Spenceley subcommittee suffer tell testify testimony Texas Thank therapy tients tion told treat treatment treatment IND tumor understand Vriesendorp waiver Wallace Washington weeks witnesses